Aim: To investigate whether plain cone-beam computed tomography (CT) immediately after conventional transcatheter arterial chemoembolization (c-TACE) can help to predict tumor response semiquantitatively in patients with hepatocellular carcinoma (HCC).
INTRODUCTION
T RANSCATHETER ARTERIAL CHEMOEMBOLIZATION is the first-line therapy recommended for patients with intermediate HCC. [1] [2] [3] [4] Contrast-enhanced CT or magnetic resonance imaging is commonly used to evaluate the efficacy of c-TACE 5 ; however, the guidelines state that the evaluation should be delayed by at least 1 month because iodized oil in viable areas is washed out gradually, even if it filled the tumor immediately after c-TACE. [6] [7] [8] [9] [10] Consequently, a time lag between treatment and evaluation of outcome can arise, and retreatment may be delayed in HCC patients with rapid progressive recurrence.
Cone-beam CT angiography is a substantial advancement in interventional radiology. Several studies have shown that cone-beam CT angiography can be helpful during TACE, mostly in cases of complex hepatic arterial anatomy. [11] [12] [13] [14] [15] [16] [17] Additionally, postprocedural plain conebeam CT can also detect the iodized oil uptake in HCCs, 18, 19 and the appearance of iodized oil uptake can be used as an endpoint of the c-TACE procedure. The gray-level values of different soft tissues in the same image remain proportional to their HU values, 20 although the grayscale values of cone-beam CT are not strictly calibrated to conform to HU measurements. It is thus possible to obtain pseudo-HUs from cone-beam CTs. Postprocedural plain cone-beam CT is supposed to distinguish induced necrotic lesions from residual or recurring lesions by assessing the degree of iodized oil accumulation in HCCs. Its use might therefore be beneficial in resolving the time lag problems. The purpose of this study was to assess the usefulness of the combination of the grayscale voxel values and morphology of iodized oil uptake in HCCs on postprocedural plain cone-beam CT as an early predictor of c-TACE response in HCC patients.
MATERIALS AND METHODS

Study cohort
A PPROVAL FOR THIS retrospective study was obtained from the local ethical review board. Written informed consent to perform c-TACE was obtained from all patients before treatment.
This cohort study was carried out as a retrospective analysis in a single institution. The study included HCC patients who underwent the c-TACE procedure and who had undergone immediate postprocedural plain conebeam CT and contrast-enhanced multiple-phase CT 1-4 months after c-TACE from April 2011 to July 2014. Patients were considered eligible for c-TACE if the diagnosis of HCC was confirmed by typical radiologic findings 1 month before c-TACE. Additional eligibility criteria included a single large or multiple HCC, naïve or recurrent HCC, Child-Pugh class A or B disease, absent or trace ascites, albumin level > 2.0 g/dL, alanine aminotransferase and aspartate aminotransferase levels of less than five times the upper normal limit, total serum bilirubin level <3.0 mg/dL, prothrombin time -international normalized ratio <1.5, serum creatinine level <2.0 mg/dL, platelet count of at least 30 000/mm, 3 and at least partial patency of the portal venous system. Patients with metal spine implants or metallic materials after interventions/abdominal surgery had to be excluded because of their metal artifacts.
Patient demographics
One hundred and sixty-nine patients with 262 unresectable HCCs were included in our study ( Table 1) . The patient population included 125 men and 44 women (age range, 43-88 years; mean ± SD, 73.9 ± 7.4 years). The maximal diameter of the tumors ranged from 0.5 to 8.9 cm (mean ± SD, 2.3 ± 1.2 cm) on contrast-enhanced CT. Each injection was carried out in a superselective (160 patients) or selective (9 patients, 3 in the right hepatic artery and 6 in the left hepatic artery) manner in the case of unifocal lesions or those with multiple feeding vessels, respectively.
Conventional TACE technique
All c-TACE procedures were carried out by two experienced interventional hepatologists and one experienced interventional radiologist (M.T, Y.M, and Y.Y, with 12, 18, and 20 years of experience, respectively), using a consistent approach.
The celiac artery was selectively catheterized using a 4-Fr. catheter. A 2.2-Fr. microcatheter (Shirabe; Piolax, Yokohama, Japan) was advanced coaxially through the catheter into the common or proper hepatic artery. Hepatic angiography was used for evaluation of the feeding vessels, and revealed a single large or multiple HCC in the liver. A microcatheter was positioned as close to the tumor bed as possible before infusion of the emulsion. In HCC patients with multiple feeders, the position of the microcatheter was changed within the same session, and both segmental c-TACE and subsegmental c-TACE were carried out. Chemoembolization was carried out using 10-30 mg epirubicin (Nippon Kayaku, Tokyo, Japan) dissolved in 1-3 mL distilled water and emulsified with 1-5 mL iodized oil (Lipiodol Ultra-Fluid; Guerbet, Paris, France) followed by the injection of gelatin sponge particles (Gelpart; Nipponkayaku, Tokyo, Japan) 1-2 mm in diameter. The dose of the emulsion depended on the tumor size and vascularity (maximal volume of emulsion, 8 mL). Once slowing of the blood flow was observed after administration of the emulsion, only a small amount of embolic was needed to reach the embolization end-point. However, the occlusion by gelatin sponge particles was often temporary and flow recovered within a few minutes, and a stronger embolic effect was required. 21 The endpoint for the administration was stasis in tumor feeding arteries with or without the appearance of iodized oil in portal vein branches. The findings of postprocedural plain cone-beam CT were not used to tailor the c-TACE procedure.
Cone-beam CT
Plain cone-beam CT was undertaken immediately after c-TACE instead of post-embolization digital subtraction angiography. C-arm cone-beam CT images were obtained using an Innova 4100 IQ pro angiographic unit (GE Healthcare, Chalfont St. Giles, UK). Cone-beam CT images were acquired using the following parameters: total scanning angle, 200°; rotation speed, 20°/s; acquisition time, 10 s; matrix size, 1500 × 1500; isotropic voxel size, 0.2 mm; and effective field-of-view, 18 cm.
2 During rotation, 300 images were obtained at a frame rate of 30 frames/s. The acquired images were then transferred to an external workstation (Advantage Workstation 4.2; GE Healthcare) where a volume dataset was reconstructed from the CT type dataset consisting of many sections with the thickness of one voxel and visualized with a volume rendering technique.
Imaging data evaluation
Axial maximum intensity projection images were obtained with a 5-mm slice thickness and 2.5-mm interposition. According to the area of iodized oil accumulation in isolation (excellent, 100% deposition of iodized oil in the lesion; good, 50-99%; fair, 1-49%; poor, 0%), 9 the subjective analysis of iodized oil uptake was evaluated based on the largest diameter dimension of the tumor by a hepatologist (Y.M., with 18 years of experience in abdominal CT interpretation) who was unaware of the tumor response assessment. Moreover, on a computer monitor with implementation of a Picture Archiving and Communication System in our hospital, an ROI was drawn on the target lesion manually as large as possible to contain the whole tumor on plain cone-beam CT. Soon thereafter, the mean voxel gray value and area (cm 2 ) were automatically calculated by multiplying the number of voxels by the unit volume of a voxel.
Final treatment response was blindly assessed at 1-4 months of CT follow-up (mean 58 days, median 51 days, range 28-120 days) by two radiologists (M.T and T.M, with 20 and 29 years of experience, respectively) using mRECIST. 22 
Statistical analysis
Receiver-operating characteristic curve analyses were used to determine the appropriate cut-off points for the prediction of complete response of c-TACE. Finally, mRECIST assessment and early prediction using the retention pattern of iodized oil, the cut-off value of the density, and the combination of the cut-off density value and retention pattern of iodized oil in HCCs on postprocedural cone-beam CT were compared.
Data are expressed as the mean ± SD, and the Pearson χ 2 -test was used to test for differences in the distribution of categorical variables. The ROC curves and the AUC were calculated to evaluate whether mean voxel gray values in HCCs on postprocedural plain cone-beam CT predict a complete response on follow-up CT. A cut-off mean voxel gray value in HCC was determined for the optimal differentiation between complete response and incomplete response. For predicting c-TACE response, the sensitivity, specificity, positive predictive value, and negative predictive value were each obtained based on the retention pattern of iodized oil, the cut-off value of the density, and the combination of them on postprocedural cone-beam CT.
Data were analyzed using statistical software (SPSS 12.0; SPSS, Chicago, IL, USA). Significance of statistical tests was taken at P < 0.05.
RESULTS
Tumor response at follow-up CT: Assessment with mRECIST
According to target response analysis, contrast-enhanced CT obtained at 1-4 months of follow-up indicated mRECIST complete response in 72.9% (191/262), partial response in 6.1% (16/262), stable disease in 16.8% (44/ 262), and progressive disease in 4.2% (11/262 ). This contrast-enhanced CT was carried out, on average, 57.8 days after c-TACE (median, 51 days; range, 28-120 days). During the first half of the follow-up period, complete response was achieved in 71.3% (107/150).
Complete response was achieved in 65.2% (73/112) during the second half of the follow-up period. There was no significant difference in treatment response assessment between the first and second half of the follow-up (P = 0.29).
According to the pattern of iodized oil uptake, postprocedural plain cone-beam CT showed uptake to be excellent in 70.6% (185/262), good in 19.5% (51/ 262), fair in 9.9% (26/262), and poor in 0%. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for predicting complete response were 85.9%, 70.4, 88.6%, 64.9%, and 81.7%, respectively, due to excellent uptake on cone-beam CT ( Table 2) . If plain cone-beam CT immediately following c-TACE showed good grade iodized oil uptake within HCC, nodular iodized oil uptake was not often observed after a few months.
Analysis of ROC curve using mean voxel gray value at postprocedural cone-beam CT and prediction of tumor response All HCCs revealed iodized oil uptake in the lesions on plain cone-beam CT immediately after c-TACE. The mean voxel gray values in HCCs ranged from 20 to 1113 (mean ± SD, 364 ± 244). Figure 1 shows that the AUC of voxel values was 0.86 (95% confidence interval, 0.81-0.91). Based on the values of sensitivity and specificity, voxel value 200.13 was selected as the cut-off. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for predicting complete response were 86.4%, 80.3, 92.2%, 68.7%, and 84.7%, respectively, with a cut-off voxel value of 200. Actually, some HCCs showed heterogeneous iodized oil accumulation with higher mean voxel values in the ROI than the cut-off level.
With a cut-off voxel value of 200 and excellent iodized oil retention, the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for predicting complete response were 86.4%, 95.8%, 98.2%, 72.3%, and 88.9%, respectively ( Table 3 ). The predictive accuracy was significantly better than that of the pattern of iodized oil retention alone (P = 0.019) ( Table 4) .
DISCUSSION
E VEN IF THE iodized oil uptake was considered to be good, washout during follow-up sometimes suggested the presence of a viable tumor. For additional diagnostic value of early prediction of c-TACE response, our study investigated whether plain cone-beam CT immediately after c-TACE can help to predict tumor response semiquantitatively in patients with HCC. According to the ROC curve of voxel values as a predictor of complete response, an AUC of 0.86 gave a good correlation, with an optimal cut-off voxel value of 200. The sensitivity, specificity, and accuracy were 85.9%, 77.4%, and 83.6%, respectively. The diagnostic accuracy was shown to be better than that of the pattern of iodized oil retention alone, but was limited because some HCCs showed heterogeneous iodized oil accumulation. Recurrences often occurred at areas of lower voxel value in HCCs. In practical situations, using the only numeric value of the mean voxel value in the ROI has a limited capacity for improving the accuracy of tumor response assessment. Therefore, two indices of lesion density and morphology were applied using plain cone-beam CT on early prediction of c-TACE. Combining the cut-off and excellent iodized oil retention, the sensitivity, specificity, and accuracy for predicting complete response were 86.4%, 95.8%, and 88.9%, respectively. The predictive accuracy was significantly better than that of the iodized oil uptake pattern alone (P = 0.019). Our results showed that the combination of the cut-off mean voxel gray value and iodized oil retention pattern was positively associated with treatment response assessment per nodule, and could assist in accurate prediction of the response to therapy. Several researchers have undertaken studies to determine whether cone-beam CT would be appropriate for evaluating the therapeutic efficacy and treatment response after TACE. [23] [24] [25] [26] Yu et al. reported that well-defined strong arterial enhancement on cone-beam CT was a statistically significant independent predictor of the therapeutic response to c-TACE (OR, 8.08; P = 0.05). 24 Intraprocedural dual-phase cone-beam CT could be used immediately after TACE with doxorubicin-eluting beads to predict HCC tumor response at 1-month follow-up. Loffroy et al. reported that a significant relationship between tumor enhancement at cone-beam CT after TACE and complete and/or partial tumor response at magnetic resonance imaging was found for arterial (OR, 0.95; P = 0.023) and venous (OR, 0.96; P = 0.035) phases. 25 The imaging characteristics of different chemoembolic agents differ substantially, thus requiring different post-treatment cone-beam CT techniques. They administered embolic drug-eluting beads in TACE without using iodized oil, and plain cone-beam CT immediately after drug-eluting bead TACE dose not yield significant imaging findings because of the beads' high permeability to X-rays. It is certain that iodized oil can also easily accumulate in well-enhanced HCCs; however, cone-beam CT hepatic arteriography was not routinely performed in this study. The density enhancement of cone-beam CT hepatic angiography might be easily affected by the volume and/or injection rate of contrast medium, or the location of the catheter tip. Moreover, it is well known that the tumor response is higher in ultraselective TACE and lower in TACE of the proximal hepatic artery. 13, 27, 28 Therefore, not pre-treatment parameters but post-treatment parameters were focused upon for early prediction of tumor response for c-TACE.
This simple early prediction also eliminates the CT radiation exposure for prediction after c-TACE. Wang et al. evaluated the capability of postprocedural cone-beam CT acquired in determining iodize oil retention when compared to 1-day unenhanced CT after TACE. 26 The mean value of tumor volume, iodized oil-deposited regions, calculated average percent iodized oil retention, and HU value of cone-beam CT were not significantly different from those of MDCT. Imai et al. compared the mean lesion density of HCCs in HUs on non-enhanced CT imaging immediately after and 1 week after c-TACE. 29 Decreased lesion density was a significant independent predictor associated with a higher local recurrence rate after c-TACE treatment (hazard ratio, 0.46; P = 0.02). In some clinical studies, CT carried out 1-3 weeks after TACE is often used for early prediction of treatment response. [29] [30] [31] Our results indicate that high density iodized oil accumulation within HCCs is difficult to wash out. It is reported that the average effective radiation dose is 8 mSv for a conventional singlephase CT examination of the abdomen and pelvis, 32 which has been associated with an estimated lifetime attributable risk of death from cancer of 0.02%. 33 Martino et al. estimated a cumulative effective dose of 30.5-43.1 mSv for a four-phase 64-section multidetector Prediction of early response of c-TACE using CBCT E117 Hepatology Research 2017; 47: E113-E119 CT (MDCT) examination of the liver 34 . Unfortunately, no data on the exposure dose from cone-beam CT could be derived from our results. However, Loffroy et al. reported that the entrance dose was 1.42 mSv ± 0.01 per cone-beam CT for radiation dosimetry experiments. 25 Cone-beam CT can deliver significantly lower doses to patients and achieves similar spatial resolution and low contrast detectability compared to standard diagnostic MDCT from a phantom study. 35 Therefore, it should be emphasized that this early prediction using plain cone-beam CT can replace conventional CT prediction.
Among HCCs with homogeneous accumulation between 150 and 220 grayscale values, the chaotic behavior of c-TACE response was shown in this study. Under this condition, some achieved complete response; however, local treatment failure occurred in the remainder. The advantage of this early prediction is convenience because the images obtained evaluate early response in a series of c-TACE procedures. However, due to the lack of information of intratumoral blood flow, this chaotic behavior could be attributed to the limit of diagnostic accuracy using plain cone-beam CT. Contrast-enhanced ultrasonography can be more sensitive and accurate to detect residual tumor after c-TACE, [36] [37] [38] but this examination must be carried out on another day following c-TACE.
On one cone-beam CT section, voxel gray values were measured in this study. Unfortunately, we could not evaluate the capability of postprocedural cone-beam CT in determining iodize oil retention volumetrically. Indeed, patients with marginal recurrence on the periphery of the tumor can be encountered. However, no application can provide tools for quantifying 3-D regions in clinical practice. The further development of computing technology is expected. In this study, voxel values were measured at the level of the maximum diameter of the tumor. As an alternative use, it might be useful to measure voxel values at the level of heterogeneous retention of iodized oil in the tumor. It would seem that most recurrences could happen at the lower voxel value area on plain cone-beam CT.
The principal limitation of this study was its retrospective design, which inherently decreases the statistical strength. Second, this study may have suffered from selection bias. Finally, voxel values in cone-beam CT are not absolute values. Naitoh et al. observed a high-level correlation between voxel values of cone-beam CT and bone mineral densities of MDCT (r = 0.965). 39 However, it can be supposed that the correlation between voxel values in cone-beam CT and MDCT could become lower at the level of soft tissue. Therefore, the cut-off value of 200 might not have relevance outside of this specific platform.
In conclusion, poor iodized oil accumulation was an unfavorable predictor in HCC patients treated with c-TACE. The pattern of iodized oil uptake on postprocedural cone-beam CT taken alone did not sufficiently correspond to 1-4 months of follow-up mRECIST assessment. The combination of density and visual estimate of homogeneity is superior to either alone in predicting tumor response of c-TACE in HCC patients.
